EVH Evolent Health Inc

Price (delayed)

$19.69

Market cap

$2.29B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.26

Enterprise value

$2.77B

Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care ...

Highlights
The revenue has grown by 47% YoY and by 11% from the previous quarter
The company's equity rose by 10% YoY
Evolent Health's net income has shrunk by 187% YoY but it has increased by 14% QoQ
EVH's gross profit is up by 25% year-on-year but it is down by 2.8% since the previous quarter
The gross margin has contracted by 14% YoY and by 12% from the previous quarter

Key stats

What are the main financial stats of EVH
Market
Shares outstanding
116.21M
Market cap
$2.29B
Enterprise value
$2.77B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.85
Price to sales (P/S)
1.03
EV/EBIT
N/A
EV/EBITDA
51.83
EV/Sales
1.27
Earnings
Revenue
$2.18B
EBIT
-$70.28M
EBITDA
$53.37M
Free cash flow
$130.43M
Per share
EPS
-$1.26
Free cash flow per share
$1.14
Book value per share
$10.65
Revenue per share
$19.06
TBVPS
$6.97
Balance sheet
Total assets
$2.64B
Total liabilities
$1.41B
Debt
$643.07M
Equity
$1.23B
Working capital
$10.22M
Liquidity
Debt to equity
0.52
Current ratio
1.02
Quick ratio
0.98
Net debt/EBITDA
8.96
Margins
EBITDA margin
2.5%
Gross margin
20.6%
Net margin
-4.5%
Operating margin
-2.6%
Efficiency
Return on assets
-5.3%
Return on equity
-12.1%
Return on invested capital
-10.9%
Return on capital employed
-3.5%
Return on sales
-3.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
0.36%
1 week
-1.55%
1 month
-15.09%
1 year
-31.44%
YTD
-40.39%
QTD
2.98%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$2.18B
Gross profit
$447.36M
Operating income
-$55.94M
Net income
-$96.97M
Gross margin
20.6%
Net margin
-4.5%
Evolent Health's net income has shrunk by 187% YoY but it has increased by 14% QoQ
The company's operating income has shrunk by 124% YoY and by 5% QoQ
The net margin has shrunk by 96% YoY but it has increased by 22% QoQ
The operating margin has plunged by 53% YoY but it has increased by 3.7% from the previous quarter

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
1.85
P/S
1.03
EV/EBIT
N/A
EV/EBITDA
51.83
EV/Sales
1.27
EVH's price to book (P/B) is 38% lower than its last 4 quarters average of 3.0 and 34% lower than its 5-year quarterly average of 2.8
The company's equity rose by 10% YoY
The revenue has grown by 47% YoY and by 11% from the previous quarter
The price to sales (P/S) is 46% lower than the 5-year quarterly average of 1.9 and 43% lower than the last 4 quarters average of 1.8

Efficiency

How efficient is Evolent Health business performance
The ROE has plunged by 163% YoY but it has grown by 3.2% from the previous quarter
Evolent Health's return on assets has shrunk by 152% YoY
The ROS has soared by 60% YoY and by 57% QoQ
EVH's return on invested capital has surged by 51% since the previous quarter and by 51% year-on-year

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 87% higher than its total liabilities
The total liabilities has increased by 9% YoY
The company's total assets rose by 2.1% YoY
The debt is 48% lower than the equity
EVH's debt to equity is down by 16% year-on-year
The company's equity rose by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.